Reema R Mody

5PUBLICATIONS
3CO-AUTHORS
Epidemiological modellingTime-series analysisPharmacogenomicsEconomic models and forecastingBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 04, 2025
Association of tirzepatide with glycaemic control and weight loss in a real world cohort of patients with type 2 diabetes from the United States.

Reema Mody, Karishma Desai, Chia-Chen Teng

|Jan 10, 2025
Characteristics and Dosing Patterns of Tirzepatide Users with Type 2 Diabetes in the United States.

Reema Mody, Karishma Desai, Chia-Chen Teng

|Sep 28, 2023
Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States.

Reema R Mody, Kellie L Meyer, Jennifer M Ward

|Jan 19, 2023
Long-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States.

William J Valentine, Meredith Hoog, Reema Mody

|Sep 21, 2022
Real-World Treatment Patterns of Glucose-Lowering Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease or At Risk for Cardiovascular Disease: An Observational, Cross-Sectional, Retrospective Study.

Radhika Nair, Reema Mody, Maria Yu

Pageof 1

Frequent Collaborators

1 joint publications

Richard Pollock

1 joint publications

Karishma Desai

1 joint publications

Michael Grabner